Advertisement - Members don't see this ad
Took them several years to routinely approve IMRT in stage 3 lung after the 0618 dosimetric study came out. So obvious these pts should have been getting it all along without stupid 3D plan comparisonsNot to derail from breast, but I had a real oh f*** moment recently. Evicore tried to deny neoadjuvant CRT for a low rectal cancer because in their algorithm, radiation is not indicated for rectal cancer. No note from surgery explicitly recommending radiation = no monies. Because of a single non-inferiority trial.
And don’t expect randomized evidence to save us..These same a** clowns won’t approve 35 fractions for intact prostate a la FLAME and will say with a straight face they need a confirmatory trial to change their algorithm and approve more than 28 fractions. Even though a single non-inferiority trial will suffice to stop approving radiation for another disease site.
Probably because we have such a weak lobby everywhere compared to med onc even though we are a drop in the bucket, cost wise